Sugentech Inc. (KOSDAQ:253840)

South Korea · Delayed Price · Currency is KRW

4,350.00

-95.00 (-2.14%)

Sep 1, 2026, 3:30 PM KST

-36.03% (1Y)

Market Cap	67.96B -34.6%
Revenue (ttm)	9.78B -16.0%
Net Income	-23.00B
EPS	-1,503.55
Shares Out	15.29M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	284,308
Open	4,430.00
Previous Close	4,445.00
Day's Range	4,300.00 - 4,440.00
52-Week Range	3,530.00 - 8,250.00
Beta	0.58
Analysts	n/a
Price Target	n/a
Earnings Date	Nov 13, 2026

About Sugentech

Sugentech Inc. develops and sells in-vitro diagnostic systems and products based on biotechnology, information technology, and nanotechnology in South Korea and internationally. The company offers lab tests, including systems and test items; and COVID-19 tests. It also provides point of care testing analyzers and test items for testing of influenza A/B, antibody test, COVID-19 and flu, SARS-CoV-2, HbA1c, beta-hcg, YSH, T3/T4, and CRP; and digital health and home tests, including mobile health, ovulation, and pregnancy products. The company was ... [Read more]

Industry Medical Devices

Sector Healthcare

Founded 2011

Employees 144

Stock Exchange KOSDAQ

Ticker Symbol 253840

Full Company Profile

Financial Performance

In 2025, Sugentech's revenue was 9.42 billion, a decrease of -6.74% compared to the previous year's 10.10 billion. Losses were -23.31 billion, 53.5% more than in 2024.

Financial Statements